Nishadil
Signup Signin
Delhi | 25°C (windy)
FDA Grants Priority Review to Rocket Pharma's Groundbreaking Gene Therapy for Rare LAD-I

FDA Grants Priority Review to Rocket Pharma's Groundbreaking Gene Therapy for Rare LAD-I
FDA Extends Review for Denali's Hunter Syndrome Breakthrough: A Closer Look at Tividenofusp Alfa's Path to Approval

FDA Extends Review for Denali's Hunter Syndrome Breakthrough: A Closer Look at Tividenofusp Alfa's Path to Approval
Ascendis Pharma Charts Course for EU Approval of TransCon CNP, Offering New Hope for Achondroplasia

Ascendis Pharma Charts Course for EU Approval of TransCon CNP, Offering New Hope for Achondroplasia
Novo Nordisk's Groundbreaking Hemophilia A Treatment Nears FDA Review

Novo Nordisk's Groundbreaking Hemophilia A Treatment Nears FDA Review
Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers

Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers
Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success

Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success
Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining

Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining
A New Dawn for RRP Patients: Papzimeos Secures Landmark FDA Approval, Redefining Care

A New Dawn for RRP Patients: Papzimeos Secures Landmark FDA Approval, Redefining Care
Load more..